Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 115-120

  Stieg, Philip E ^a   Sathi, Sumeer ^a   Warach, Steven ^b   Le, Dean A ^a   Lipton, Stuart A ^a  

^a CNS Research Institute   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Focal cerebral ischemia; Memantine; Neonatal, rat; Photochemical thrombosis

Indexed keywords

MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; STROKE; THROMBOSIS;

ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; INFARCTION; LIGHT; MAGNETIC RESONANCE IMAGING; MEMANTINE; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; THROMBOSIS;

EID: 0033019327     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00214-9     Document Type: Article

References (36)

1. Allegrini P.R., Sauer D. Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis. Magnetic Resonance Imaging. 10:1992;773-778.
2. Benveniste H., Dryer J., Schousboe A., Diemer N.H. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
3. Bormann J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol. 166:1989;591-592.
4. Cai H., Yao H., Ibayashi S., Uchimura H., Fujishima M. Photothrombic middle cerebral artery occlusion in spontaneously hypertensive rats: influence of substrain, gender, and distal middle cerebral artery patterns on infarct size. Stroke. 29:1998;1982-1987.
5. 2+-dependent mechanisms of cell injury in cultured cortical neurons. Neuroscience. 86:1998;1133-1144.
6. Chen H.-S.V., Lipton S.A. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. (London). 499:1997;27-46.
7. Chen H.-S.V., Pellegrini J.W., Aggarwal S.K., Lei S.Z., Warach S., Jensen F.E., Lipton S.A. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12:1992;4427-4436.
8. Chen H.-S.V., Wang Y.F., Raydu P.Y., Edgecomb P., Neill J.C., Segal M.M., Lipton S.A., Jensen F.E. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience. 86:1998;1121-1132.
9. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
10. Choi D.W. Cerebral hypoxia: some new approaches and unanswered questions. J. Neurosci. 10:1990;2493-2501.
11. De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen P.A. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke. 20:1989;1383-1390.
12. Gill R., Foster A.C., Woodruff G.N. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J. Neurosci. 10:1987;33-39.
13. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vöckler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
14. 3H ]MK-801 at therapeutic concentrations in postmortem human frontal cortex Eur. J. Pharmacol. 166:1989;589-590.
15. Levy D.I., Lipton S.A. Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology. 40:1990;852-855.
16. Lipton S.A. Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 15:1992;75-79.
17. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
18. Maj V.J. Die wirkung von memantin auf 2 entrale neuro-transmittersysteme. Drug Res. 32:1982;1250-1258.
19. Manning W.J., Wei J.Y., Fossel E.T., Burstein D. Measurement of left ventricular mass in rats using electrocardiogram-gated magnetic resonance imaging. Am. J. Physiol. 258:1990;H1181-H1186.
20. McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15:1990;41-70.
21. McDonald J.W., Silverstein F.S., Johnston M.V. Neuroprotective effects of MK-801, TCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res. 490:1989;33-40.
22. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional expression of four NMDA receptors. Neuron. 12:1994;529-540.
23. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
24. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518.
25. Rod M.R., Auer R.N. Dizocilpine (MK-801) reduces cerebral necrosis in the rat. Can. J. Neurol. Sci. 16:1989;340-344.
26. Rogers D.C., Hunter A.J. Photothrombotic lesions of the rat cortex impair acquisition of the water maze. Pharmacol. Biochem. Behav. 56:1997;747-754.
27. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic ischemic brain damage. Ann. Neurol. 19:1986;105-111.
28. Seif el Nasr M., Perucher B., Rossberg C., Mennel H.-D., Krieglstein J. Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur. J. Pharmacol. 185:1990;19-24.
29. Sheng M., Cummings J., Roldan L.A., Jan Y.N., Jan L.Y. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature. 368:1994;144-147.
30. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
31. Swan J.H., Meldrum B.S. Protection by NMDA antagonists against selective cell loss following transient ischemia. J. Cereb. Blood Flow Metab. 10:1990;343-351.
32. Volpe, J.J., 1993. Neurology of the Newborn, 3rd edn. W.B. Saunders, Philadelphia, PA.
33. Warnick J.E., Maleque M.A., Bakry N., Eldefrawi A.T., Albuquerque E.X. Structure-activity relationships of amantadine: I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Mol. Pharmacol. 22:1982;82-93.
34. Watson B.D., Dietrich W.D., Busto R., Wachtel M.S., Ginsberg M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 17:1985;497-504.
35. Wesemann W., Schollmeyer J.D., Sturm G. Distribution of memantine in brain, liver and blood of the rat. Drug Res. 32:1982;1243-1245.
36. Wesemann W., Sontag K.-H., Maj J. Zur Pharmakidynamik und Pharmakokinetik des Memantin. Arzneim-Forsch./Drug Res. 33:1983;1122-1134.